| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.006 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |